Cynthia Cetani
Compliance Officer chez INDIVIOR PLC
Fortune : 4 M $ au 31/03/2024
Profil
Cynthia Cetani is currently the Chief Compliance & Integrity Officer at Indivior PLC since 2018.
Prior to this, she worked as the Head-Compliance Operations & Group Integrity at Novartis AG and as the Chief Compliance Officer at Novartis Pharmaceuticals Corp.
Ms. Cetani is a graduate of Rider University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INDIVIOR PLC
0,14% | 01/03/2024 | 187 810 ( 0,14% ) | 4 M $ | 31/03/2024 |
Postes actifs de Cynthia Cetani
| Sociétés | Poste | Début |
|---|---|---|
| INDIVIOR PLC | Compliance Officer | 01/10/2018 |
Anciens postes connus de Cynthia Cetani
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Compliance Officer | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Compliance Officer | - |
Formation de Cynthia Cetani
| Rider University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INDIVIOR PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
